XML 66 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Instruments and Risk Management (Schedule of Gains and Losses on Derivative Instruments) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]     Nonoperating Income (Expense) Nonoperating Income (Expense)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]     Nonoperating Income (Expense)  
FX contract | Designated as hedge | Cash flow hedge        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain (loss) recognized in OCI $ 1.3 [1] $ 3.1 [1] $ (5.8) $ 4.9
Gain (loss) reclassified from AOCI into income (effective portion) [1],[2]     $ 0.9 $ 1.6
FX contract | Designated as hedge | Cash flow hedge | Other expense (income), net        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]        
FX contract | Not designated as hedge | Other expense (income), net        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]        
[1] Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk.
[2] Gain was recorded in Other expense (income), net.